Advertisement

Topics

Triphase Accelerator Corporation Company Profile

02:09 EDT 19th July 2018 | BioPortfolio

Triphase Accelerator is a private drug development company with a primary focus on oncology and with operations in Toronto and San Diego. Triphase Accelerator is dedicated to advancing novel compounds through Phase 2 proof-of-concept clinical studies using a unique, science-based, high-quality model that is faster and more cost-effective than traditional pharmaceutical and biotech industry drug development approaches. Triphase Accelerator was spun out of the Ontario Institute for Cancer Research (OICR), with support from the Fight Against Cancer Innovation Trust (FACIT), MaRS Innovation and MaRS. It has a strategic relationship with Celgene for oncology-focused drug development opportunities. For more information, visit www.triphaseco.com or Linkedin.


News Articles [224 Associated News Articles listed on BioPortfolio]

Triphase Accelerator Corp Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 15032018] Prices from USD $250

SummaryTriphase Accelerator Corp Triphase Accelerator is a drug development company that acquires and develops cancer therapies from preinvestigational new drug stage to Phase I or Phase II proof of c...

Global Brand Consultancy to Launch STEAM Focused Accelerator Hub at its Leeds HQ

Global brand design consultancy Elmwood, is set to launch its first accelerator programme in June 2018. Elmwood LaunchPod is a unique project bringing creative and technology start-ups together into a...

Largest Startup Class Yet Enters UC Berkeley’s Expanding Accelerator

More than a hundred startup teams are beginning a training and mentoring program this month at the Berkeley SkyDeck Accelerator—the largest group ever accepted to the UC Berkeley program since i...

Restek Releases the GC Accelerator Kit: Same Separation, Speedier Solution

Designed with GC-MS users in mind, Restek's GC Accelerator kit provides a simple way to speed up sample analysis

Boomtown, COPIC Launch Patient Safety HealthTech Startup Accelerator

Boulder, CO-based startup accelerator Boomtown and COPIC, a medical liability insurance provider recognized for its innovative patient safety and risk management, have announced a multi-year agreement...

Accelerator Life Science Partners launches new company to develop novel therapy for seizure disorders

Accelerator Life Science Partners (Accelerator), a leading life science investment and management firm, today announced that it has launched Proniras Corporation, a company developing tezampanel for t...

Microsoft Accelerator Beijing anticipe l'avenir, en regroupant les besoins du secteur et en ...

Microsoft Accelerator est un programme mondial qui aide les startups à croître, grâce à des relations commerciales puissantes et à des connaissances techniques. À travers Read more...

AbbVie and Rice University Establish K.C. Nicolaou Research Accelerator to Advance Therapies in Oncology

NORTH CHICAGO, Ill. and HOUSTON, April 30, 2018 /PRNewswire/ — AbbVie, a research-based global biopharmaceutical company, and Rice University today announced they have entered into a joint resea...

PubMed Articles [54 Associated PubMed Articles listed on BioPortfolio]

A photon source model based on particle transport in a parameterized accelerator structure for Monte Carlo dose calculations.

An accurate source model of a medical linear accelerator is essential for Monte Carlo (MC) dose calculations. This study aims to propose an analytical photon source model based on particle transport i...

An ultrasensitive electrochemiluminescence biosensor for detection of MicroRNA by in-situ electrochemically generated copper nanoclusters as luminophore and TiO as coreaction accelerator.

Herein, we constructed an ultrasensitive electrochemiluminescence (ECL) biosensor for detecting microRNA-21 (miR-21) based on in-situ generation of copper nanoclusters (Cu NCs) as luminophore and tita...

Design considerations for a Pulse Line Ion Accelerator (PLIA)-based PET isotope generator.

Positron emission tomography (PET) imaging remains limited by the cost associated with on-site production of short half-life, positron emitting isotopes. In this work, we examine the use of a pulse li...

EURADOS intercomparison exercise on Monte Carlo modelling of a medical linear accelerator.

In radiotherapy, Monte Carlo (MC) methods are considered a gold standard to calculate accurate dose distributions, particularly in heterogeneous tissues. EURADOS organized an international comparison ...

Towards femtosecond-level intrinsic laser synchronization at fourth generation light sources.

In this Letter, the proof of principle for a scheme providing intrinsic femtosecond-level synchronization between an external laser system and fourth generation light sources is presented. The scheme ...

Clinical Trials [18 Associated Clinical Trials listed on BioPortfolio]

First-In Man (FIM) Study MR-Linac

Investigational device is the Magnetic resonance imager linear accelerator. Five (5) patients with bone metastases will be treated with palliative intention in this study. The goal is to c...

Evaluation of Capsulotomy by Linear Accelerator Radiosurgery in Severe and Refractory Obsessive-compulsive Disorder

The aim of this study is to evaluate, through a pilot study with about ten cases, if bilateral ventral capsulotomy by linear accelerator enable modification of obsessive-compulsive symptom...

Stereotactic Body Radio Therapy (SBRT) for Early-Stage Non Small Cell Lung Cancer (NSCLC)

The purpose of this study is to evaluate local disease control after 2 years in patients with non-metastatic, non-operated non-small-cell lung cancer treated by radiotherapy. Eligible pat...

Autoimmune Diabetes Accelerator Prevention Trial

The autoimmune diabetes ACCELERATOR PREVENTION TRIAL (adAPT) is based on the accelerator hypothesis. The trial is designed to establish whether metformin, an oral hypoglycaemic agent that ...

Trilogy Stereotactic Body Radiotherapy for Pancreatic Cancer

This study will assess the efficacy of treating locally advanced pancreatic cancer using a linear accelerator designed for image-guided radiotherapy

Companies [235 Associated Companies listed on BioPortfolio]

Triphase Accelerator Corporation

Triphase Accelerator is a private drug development company with a primary focus on oncology and with operations in Toronto and San Diego. Triphase Accelerator is dedicated to adva...

Triphase

Triphase is a private, oncology- focused accelerator dedicated to advancing compelling, well differentiated drugs through human proof of concept (Phase II) faster and more efficie...

Accelerator Life Science Partners

Accelerator Life Science Partners catalyzes the development and commercialization of breakthrough biotechnology innovations. Accelerator is a trusted partner that provides the com...

Cydan

Cydan is an orphan drug accelerator that identifies and de-risks assets with therapeutic and commercial potential. The accelerator’s model evaluates programs for treating rar...

SKTA Innopartners

SKTA Innovation Accelerator is a different kind of accelerator based in Silicon Valley. We seed core technology startups by matching entrepreneurs with Strategic Partners committe...

More Information about "Triphase Accelerator Corporation" on BioPortfolio

We have published hundreds of Triphase Accelerator Corporation news stories on BioPortfolio along with dozens of Triphase Accelerator Corporation Clinical Trials and PubMed Articles about Triphase Accelerator Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Triphase Accelerator Corporation Companies in our database. You can also find out about relevant Triphase Accelerator Corporation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record